Image 1_Sediment exposure decreases diversity in the surface mucus layer microbiome of Porites lobata at Honoliʻi, Hawaiʻi.jpeg by Joseph W. P. Nakoa (21796214)

Table 1_Sediment exposure decreases diversity in the surface mucus layer microbiome of Porites lobata at Honoliʻi, Hawaiʻi.xlsx by Joseph W. P. Nakoa (21796214)

A. Bar chart showing the percentage of participants experiencing chills in response to various stimuli, ordered by descending frequency. by Felix Alexandre Schoeller (20988295)

Photosynthesis and respiration rates of (A) <i>Acropora</i> sp. and (B) <i>P. verrucosa</i> for the four groups. by Malte Ostendarp (13217973)

Subjects:

Table 1_Food scarcity and decrease in income are associated with depression after COVID-19 pandemic in rural settings.docx by Dharmendra Gahwai (20987825)

The global changes of prevalence (A-C), DALYs (D-F), and mortality (G-I) rates of IBD among WCBA from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects:

The weighted UniFrac (A) and PCoA (B) analysis of bacterial samples in passion fruit rhizosphere soil. by Weiwei Lin (2442850)

Subjects:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

The characteristics and clinical features of 12 patients. by Masashi Okawa (8951294)

Subjects:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

Subjects:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Subjects:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. by Masashi Okawa (8951294)

Subjects:

The original data for the figures. by Masashi Okawa (8951294)

Subjects:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. by Masashi Okawa (8951294)

Subjects:

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Hypothetical mechanism by which plasma VEGF-A121 concentration is elevated post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Breaking strength and ash contents in the tibia. by Miloš Skřivan (5122037)

Subjects:

Performance characteristics of broilers. by Miloš Skřivan (5122037)

Subjects:

Digesta viscosity and pH in the ileum. by Miloš Skřivan (5122037)

Subjects: